Roche coaches docs, RNs on diabetes

Share this article:

Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff to improve dialogue between diabetic patients and their caregivers.


Titled "Creative Coaching," the program helps healthcare professionals with "the art of patient engagement," said Luc Vierstraete, SVP and general manager of Roche's US diabetes unit, in a statement.
"A worldwide strategic objective for Roche is to enable diabetes management," said Vierstraete. "We take this very seriously. In the US alone, we have invested more than $14 million in the overall campaign. By locking arms with these dedicated healthcare professionals and providing them with a forum to improve patient self-care, we feel certain this can be achieved."


"What I appreciated most was the purpose of the weekend [program], which was to increase the quality of our healthcare," said Linda Filipi, a California-based registered nurse, in the statement. "For us that means how to become better educators—for Roche, it is how to offer quality products."


Roche manufactures the Accu-Chek line of blood glucose monitors. 
The professional education program, Behavior Change through Patient Engagement, is multifaceted and includes a website with online tools and information, as well as how to effectively integrate Accu-Chek products into their practice.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...